Background illustration for clinical trials search

Paid Clinical Trials Chicago

Discover 2,382 paid clinical trials in Chicago, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

for
Acute Myeloid Leukemia, Mixed Lineage Leukemia Gene Mutation,
Location: Chicago IL, Maywood IL, Milwaukee WI, Madison WI,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT05735184

Phase1, Recruiting

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

for
SLE (Systemic Lupus), Lupus Erythematosus, Systemic,
Location: Chicago IL, Iowa City IA, St Louis MO, Chapel Hill NC,
Sponsor: CRISPR Therapeutics

Sex: All

Age: 18 - 70

Code: NCT06925542

Phase1, Recruiting

SMP-3124LP in Adults With Advanced Solid Tumors

for
Solid Tumor
Location: Chicago IL, Columbus OH, Nashville TN, Denver CO,
Sponsor: Sumitomo Pharma America, Inc.

Sex: All

Age: 18+

Code: NCT06526819

Phase1, Phase2, Recruiting

Early Feasibility of the Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) Also Known as TriAlign™.

for
Chronic Symptomatic Functional Tricuspid Regurgitation,
Location: Chicago IL, Minneapolis MN, Charlottesville VA,
Sponsor: Mitralign, Inc.

Sex: All

Age: 18 - 70+

Code: NCT02574650

Recruiting

Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

for
Cervical Cancer, Endometrial Cancer, Fallopian Tube Cancer,
Location: Chicago IL
Sponsor: Northwestern University

Sex: Female

Age: 18 - 70+

Code: NCT00005095

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.

for
Solid Tumor, Lymphoma
Location: Chicago IL, Morristown NJ
Sponsor: MultiVir, Inc.

Sex: All

Age: 18+

Code: NCT03544723

Phase2, Recruiting

IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)

for
Advanced Melanoma
Location: Chicago IL, Detroit MI, Edgewood KY, Columbus OH,
Sponsor: Immunocore Ltd

Sex: All

Age: 18+

Code: NCT06112314

Phase3, Recruiting

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Chicago IL, Detroit MI, Columbus OH, Philadelphia PA,
Sponsor: Regeneron Pharmaceuticals

Sex: Female

Age: 18+

Code: NCT04590326

Phase1, Phase2, Recruiting

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

for
T-cell Lymphoma, Cutaneous/Peripheral T-Cell Lymphoma,
Location: Chicago IL, Ann Arbor MI, Detroit MI, Pittsburgh PA,
Sponsor: SciTech Development, Inc.

Sex: All

Age: 18+

Code: NCT04234048

Phase1, Recruiting

Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU

for
Non Hodgkin Lymphoma,
Location: Chicago IL, Milwaukee WI, Westwood KS, Durham NC,
Sponsor: Miltenyi Biomedicine GmbH

Sex: All

Age: 18+

Code: NCT06116110

Recruiting

VIBRANT: VIB4920 for Active Lupus Nephritis

for
Lupus Nephritis
Location: Chicago IL, Ann Arbor MI, St Louis MO, Hershey PA,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18+

Code: NCT05201469

Phase2, Recruiting

A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases

for
HER2-negative Breast Cancer Patients With Brain Metastases
Location: Chicago IL, Baltimore MD, Augusta GA, Stony Brook NY,
Sponsor: Biostar Pharma, Inc.

Sex: All

Age: 18+

Code: NCT06764940

Phase2, Recruiting

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

for
Peripheral T-Cell Lymphoma, Not Otherwise Specified,
Location: Chicago IL, Madison WI, Iowa City IA, Ann Arbor MI,
Sponsor: Corvus Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06561048

Phase3, Recruiting

Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

for
Clonal Mast Cell Disease, KIT D816V Mutation,
Location: Evanston IL, Normal IL, St Louis MO, Rochester MN,
Sponsor: Blueprint Medicines Corporation

Sex: All

Age: 18+

Code: NCT07143669

Recruiting

Collecting Tissue Samples for Future Research From Women Undergoing Surgery for Breast Cancer

for
Breast Cancer
Location: Chicago IL
Sponsor: Northwestern University

Sex: Female

Age: 0+

Code: NCT00898131

Recruiting

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

for
Lymphoma
Location: Chicago IL, St Louis MO, Columbus OH, Cleveland OH,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT07015242

Phase2, Recruiting

Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia

for
Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 14+

Code: NCT03932903

Recruiting

Study to Evaluate the Safety and Efficacy of Dermal Injections of JVS-100 Given to Adults Receiving Median Sternotomy

for
Median Sternotomy
Location: Chicago IL, Akron OH, Norfolk VA, New York City NY,
Sponsor: SironRX Therapeutics, Inc.

Sex: All

Age: 40 - 70+

Code: NCT01657045

Phase1, Recruiting

Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEF

for
Heart Failure With Preserved Ejection Fraction (HFpEF
Location: Chicago IL, Ann Arbor MI, St Louis MO, Columbus OH,
Sponsor: Axon Therapies, Inc.

Sex: All

Age: 40+

Code: NCT04592445

Recruiting

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

for
AML, AML With Mutated NPM1, Hematologic Malignancy, KMT2Ar,
Location: Chicago IL, Maywood IL, Milwaukee WI, Iowa City IA,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06001788

Phase1, Recruiting

Chicago is a vital city for clinical research, offering a robust healthcare network and renowned medical research institutions. Major facilities such as The University of Chicago Medicine, Northwestern Medicine, and Rush University Medical Center are at the forefront of pioneering research across various fields, including cancer, cardiovascular health, and neurological disorders.

Why choose Chicago for clinical trials?

The city of Chicago offers many advantages for individuals considering participation in clinical trials. With a diverse and vibrant population, researchers benefit from the variety of participants, improving the reliability and applicability of research findings across different demographics.

By opting to participate in a clinical trial in Chicago, individuals not only gain access to cutting-edge therapies and treatments but also contribute to vital medical research. This collaborative effort is supported by a robust clinical research infrastructure, ensuring participants receive high-quality care and attention while playing a crucial role in shaping the future of healthcare.

Common conditions studied in Chicago

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Chicago